Study title:
Suarez A, Stettler ER, Rey E, Pons G, Simonetta-Chateauneuf C, de Bruijn KM, Olive G, Lemerle J. "Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy." Eur J Cancer. 1994;30A(10):1436-41
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Hemic and Lymphatic Diseases
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: TROPISETRON |
ATC code: |
Document link:
Navoban ICS3 512-E-00.xls
|
Document date: 2011-09-22
|
Study number: ICS3 512 |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|